Immunoassays Market Research Reports & Industry Analysis
An immunoassay is one of the most effectual analytical tests performed due to its specificity, sensitivity and versatility. To test the concentration of a substance within a solution, immunoassay tests use specific antibodies that will react with antigens in the solution. Monoclonal antibodies provide accurate test results and are the most common antibodies used in immunoassay testing due to their ability to bind to one site of any particular molecule. To get an accurate result, the specific antibody must have a high affinity to the antigen being tested for. The number of antigens and antibodies present in the tested solution is measured. This measurement tells how much of the analyte is located within the sample and how concentrated it is.
One of the most widely used immunoassay applications for the detection of infectious disease is the enzyme-linked immunosorbant assay (ELISA). Because of its high sensitivity, the ELISA was the first screening test widely used for HIV.
Immunoassays are significant tests that perform an array of functions in conventional medicine. While it is used primarily to test for things such as HIV in the body, the test can also be used to discover new ways to test for other diseases and conditions that don’t have a direct scientific diagnostic method.
Immunoassays Industry Research & Market Reports
-
2022-2026 Emerging Immunodiagnostic Tests, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers
... Abused Drug assays, including listings of companies developing or marketing new technologies and products. The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market ... Read More
-
2022 France HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks In addition to test ... Read More
-
2022 Germany Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV , Anti-HBc , Anti-HBs , Anti-HAV , ... Read More
-
2022 Germany HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Physician Offices
... provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV , NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks In addition ... Read More
-
2022 Italy HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks In addition to test volume ... Read More
-
2022 UK Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Public Health Labs
... UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV , Anti-HBc , ... Read More
-
2022 US HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs
... the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood ... Read More
-
2022 France Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV , Anti-HBc , Anti-HBs , Anti-HAV , ... Read More
-
2022 Italy Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV , Anti-HBc , Anti-HBs , Anti-HAV , ... Read More
-
2022 USA Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs
... in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs Ag, HCV , ... Read More
-
2022 Global HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs
... in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in ... Read More
-
2022 UK HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals
... test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks - Physician Offices ... Read More
-
Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029
... Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029 The diagnostic specialty antibodies ... Read More
-
2022 Global Forecast for Veterinary Rapid Test (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027
... projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing ... Read More
-
Biodefense Market Size By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents}), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022- 2028
... 2028 The biodefense market is anticipated to grow substantially by 2028 on account of increasing government initiatives for promoting treatment strategies to develop effective vaccines to combat mutated vaccines as well as detection devices against ... Read More
-
2022-2026 France Hepatitis Diagnostic Testing Market: Supplier Shares, Volume and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Assays, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs ... Read More
-
2022-2026 US Hepatitis Diagnostic Testing Market: Supplier Shares, Volume and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Tests, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... the Hepatitis diagnostics market in US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs ... Read More
-
2022-2026 Italy Hepatitis Diagnostic Testing Market: Supplier Shares, Volume and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Tests, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs ... Read More
-
2022-2026 Germany Hepatitis Diagnostic Testing Market: Supplier Shares, Volume and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Tests, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs ... Read More
-
2022-2026 UK Hepatitis Diagnostic Testing Market: Supplier Shares, Volume and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Tests, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... the Hepatitis diagnostics market in UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT , HBV NAT , HBs ... Read More
-
2022-2026 Global Hepatitis Diagnostic Testing Market: US, Europe, Japan-Supplier Shares, Volume and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Tests, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers
... analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the 5-year test ... Read More
-
Latin America, Middle East & Africa Lateral Flow Assays Market Databank
... CAGR of 9.90% from 2021 to 2029. Kits & Reagents segment is expected to be the highest contributor to this market, with $6,679.2 Million in 2020, and is anticipated to reach $15,550.6 Million by 2029, ... Read More
-
Global Sepsis Diagnostic Market By Product (Blood Culture Media, Instruments, Assay kits & Reagents, Software), By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), By Method (Conventional Diagnostics, Automated Diagnostics), By Usability (Laboratory Testing, Point-of-care Testing), By Pathogen (Bacterial Sepsis, Fungal Sepsis, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
... By Pathogen (Bacterial Sepsis, Fungal Sepsis, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030 The global sepsis diagnostic market valued at $569.49 million in 2020, and is estimated to reach $1207.58 million by 2030, growing ... Read More
-
Hospital-Acquired Infection Diagnostics Market By Product (Instrument, Reagents and Consumables), By Test Type (Molecular Diagnostics, Immunoassay, Others), By Application (Disease Testing, Drug-Resistance Testing), By Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI), Others), By End User (Hospital, Standalone Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
... Infections, Urinary Tract Infections (UTI), Others), By End User (Hospital, Standalone Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030 The global hospital acquired infection diagnostics market was valued $3,355.28 million in 2020 and expected ... Read More
Research Assistance
